In induced pluripotent stem cells (iPSCs) of DMD patients, the AsCas12f-HKRA mutant can effectively restore the expression of dystrophin and regulate the level of plasma transthyretin (TTR) [42]. The gene discussed is TTR; the disease is Duchenne muscular dystrophy.